代谢
两名晚期(尿毒症)婴儿型肾囊性胱氨酸病(INC)的男性患者通过口服还原剂二硫苏糖醇(DTT)进行治疗,剂量不超过每天三次,每次25毫克/千克体重。在两名患者中获得了三个连续观察期:服用巯基(8.5个月);停用巯基(8-9个月);再次服用巯基(7个月或更长时间)……虽然化学方法不能可靠地检测和测量生物流体中的DTT,但初步证据表明,口服DTT的患者的尿液中可以检测到氧化DTT的硅基衍生物。这一发现表明巯基被吸收并排出体外。
Two male patients with late stage (uremic) infantile nephropathic cystinosis (INC) were treated by mouth with the reducing agent dithiothreitol (DTT), at doses not exceeding 25 mg/kg body weight three times per day. Three sequential periods of observation were obtained in both patients: on thiol (8.5 months); off thiol (8-9 months); on thiol again (7 months or longer)... Whereas chemical methods are not reliable for detecting and measuring DTT in biologic fluids, preliminary evidence indicates that a silylated derivative of oxidized DTT can be detected in the urine of patients receiving DTT by mouth. This finding suggests that the thiol is absorbed and excreted.
来源:Hazardous Substances Data Bank (HSDB)